US › Healthcare

Alpha Teknova Inc (TKNO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$7.45+4.78%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$12.2M

Revenue YoY

+18.5%

Net profit

$-3.2M

EPS

$-0.06

EPS estimate

$-0.08

Net margin

-26.0%

EPS came in at -0.06 against a street estimate of -0.08 — a beat of 25.0%.

Key statistics

Market cap

$360.2M

Forward P/E

0.0

P/B

5.75

Book value

$1.17

EPS (TTM)

$-0.31

52-week high

$7.84

52-week low

$1.91

50-day MA

$6.22

200-day MA

$4.26

Beta

0.73

Analyst view

Analysts rate Alpha Teknova Inc a buy (3 buy, 2 hold, 0 sell out of 5) with an average price target of $8.60.

Shareholding

Insiders

9.31%

Institutions

87.34%

Largest institutional holders

Fund	Stake
Roubaix Capital, LLC	2.94%
Royce & Associates, LP	1.99%
BlackRock Inc	1.34%
Vanguard Capital Management, LLC	0.82%
UBS Group AG	0.61%
Conestoga Capital Advisors, LLC	0.59%
Geode Capital Management, LLC	0.57%
Bank of America Corp	0.43%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alpha Teknova Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.